📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations. (2017)

First Author: Harausz EP

Attributed to: A phase III cluster randomised placebo-controlled trial to assess the efficacy of preventive therapy in child and adolescent contacts of MDR-TB funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201606-1227ci

PubMed Identifier: 27854508

Publication URI: http://europepmc.org/abstract/MED/27854508

Type: Journal Article/Review

Volume: 195

Parent Publication: American journal of respiratory and critical care medicine

Issue: 10

ISSN: 1073-449X